Concord Healthcare, a subsidiary of Concord Medical Services Holdings Limited, has made significant advancements in tumor diagnosis and treatment with the official release of its Proton Therapy Large Model. This large language model, the first of its kind in China, is specifically designed for proton therapy and has been successfully deployed at the Guangzhou Concord Cancer Hospital. The model leverages over 10,000 high-quality radiotherapy cases and integrates data from Proton China and professional journals to enhance its training. Since its implementation, the proton therapy at Guangzhou Concord Cancer Hospital has demonstrated precise treatment capabilities, significant efficacy, and reduced side effects in patient care. Concord Healthcare's efforts mark a notable progression in the field of precise tumor treatment.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。